Insights and News Curated for Life Science Experts by Life Science Experts....

INSIGHTS HUB

Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

Bedminster, NJ, April 11, 2023 (PRNewswire) -- Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd, a global specialty...

Mountain View, CA, April 6, 2023 (Globe Newswire) -- HeartFlow, Inc., the leader in revolutionizing precision heart care, today...

Cambridge, MA, March 22, 2023 (Business Wire) -- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies...

Washington, March 21, 2023 (AdvaMed) -- AdvaMed, the world’s leading medical technology association, announced that Ashley McEvoy,...

San Francisco, CA, March 21, 2023 (Business Wire) -- Artera, the developer of multimodal artificial intelligence-based predictive and...

Plymouth. MN, March 27, 2023 (The Business Journals) -- A former executive at Medtronic has taken the helm of an emerging medical...

Cambridge, MA, March 22, 2023 (PRNewswire) -- Flare Therapeutics Inc., a biotechnology company targeting transcription factors to...

South San Francisco, CA, March 14. 2023 (Business Wire) -- Switch Therapeutics, a preclinical stage biotechnology company pioneering a...

San Diego, CA, March 14, 2023 (Globe Newswire) -- Medical Marijuana, Inc., a holding company with operating assets dedicated to the...

Cambridge, MA, March 6, 2023 (Business Wire) -- Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action...

Research Triangle Park, NC, March 9, 2023 (PRNewswire) -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently...

New York, NY, March 13, 2023 (Reuters) -- Pfizer Inc struck a $43 billion deal to buy Seagen Inc in the U.S. drugmaker's biggest in a...